Haemonetics Corp. (HAE)
83.84
+0.63
(+0.76%)
USD |
NYSE |
Dec 09, 16:00
83.50
-0.34
(-0.41%)
Pre-Market: 20:00
Haemonetics EPS Diluted (Quarterly): 0.8116 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Azenta, Inc. | 1.106 |
| Enovis Corp. | -9.990 |
| Masimo Corp. | -1.859 |
| UFP Technologies, Inc. | 2.106 |
| Dentsply Sirona, Inc. | -2.140 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.68M |
| Revenue (Quarterly) | 327.32M |
| Total Expenses (Quarterly) | 288.63M |
| Enterprise Value | 4.853B |
| Gross Profit Margin (Quarterly) | 56.04% |
| Profit Margin (Quarterly) | 11.82% |
| Earnings Yield | 4.09% |
| Operating Earnings Yield | 5.75% |
| Normalized Earnings Yield | 4.096 |